The present disclosure relates to treating an open wound, and, more specifically, relates to a sub-atmospheric wound therapy system including a portable container adapted to maintain the operation of the system regardless of the orientation or positioning of the container.
Wound closure involves the migration of epithelial and subcutaneous tissue adjacent the wound towards the center and away from the base of the wound until the wound closes. Unfortunately, closure is difficult with large wounds, chronic wounds or wounds that have become infected. In such wounds, a zone of stasis (i.e. an area in which localized swelling of tissue restricts the flow of blood to the tissues) forms near the surface of the wound. Without sufficient blood flow, the epithelial and subcutaneous tissues surrounding the wound not only receive diminished oxygen and nutrients, but, are also less able to successfully fight microbial infection and, thus, are less able to close the wound naturally. Such wounds have presented difficulties to medical personnel for many years.
Negative pressure therapy also known as suction or vacuum therapy has been used in treating and healing wounds. Application of negative pressure, e.g. reduced or subatmospheric pressure, to a localized reservoir over a wound has been found to assist in closing the wound by promoting blood flow to the area, stimulating the formation of granulation tissue, and encouraging the migration of healthy tissue over the wound. Negative pressure may also inhibit bacterial growth by drawing fluids from the wound such as exudates, which may tend to harbor bacteria. This technique has proven particularly effective for chronic or healing-resistant wounds, and is also used for other purposes such as post-operative wound care.
Generally, negative pressure therapy provides for a wound to be covered to facilitate suction at the wound area. A conduit is introduced through the wound covering to provide fluid communication to an external vacuum source. Atmospheric gas, wound exudates, or other fluids may thus be drawn from the reservoir through the fluid conduit to stimulate healing of the wound. Exudates drawn from the reservoir may be deposited in a collection canister or container.
The systems generally require that the container is maintained in a standing or upright position such that the fluid receiving reservoir within the respective unit may be vented and continue to receive fluid from the patient until the reservoir is full. Accidental tipping or tilting of the bag and/or container may cause the suction to/from the unit to be to be shut-off prior to the fluid receiving reservoir completely filling. This problem is further exaggerated in portable units which may be worn or carried by the subject.
A portable system for subatmospheric pressure therapy in connection with healing a surgical wound includes a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum and a canister associated with the housing. The canister has a collection bag disposed therein, which is in fluid communication with the wound dressing to receive exudates from the wound bed. The collection bag is adapted to expand upon receipt of the fluids and has means to release gas from within the collection bag in connection with operation of the control unit. With this arrangement, the canister is attitude independent. i.e., the canister may be positioned on edge, on its side or on its end etc. while still maintaining operation of the control unit. The collection bag may include a hydrophobic vent or material for releasing the gases. In another embodiment, the collection bag comprises a gas permeable material. The collection bag may include one of pleats or bellows.
In another embodiment, the portable system for subatmospheric pressure therapy in connection with healing a surgical wound includes a wound dressing dimensioned for positioning relative to a wound bed of a subject and a subatmospheric pressure mechanism dimensioned to be carried or worn by the subject. The subatmospheric pressure mechanism includes a housing having a control unit adapted to draw a vacuum, a container defining an internal chamber in fluid communication with the vacuum and the wound dressing to receive the wound exudates, a plunger received within the internal chamber and movable during actuation of the control unit and a hydrophobic filter associated with the plunger and permitting escape of gas from the container.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the disclosure and, together with a general description of the disclosure given above, and the detailed description of the embodiment(s) given below, serve to explain the principles of the disclosure, wherein:
The wound therapy system of the present disclosure promotes healing of a wound via the use of a wound dressing and a portable subatmospheric pressure mechanism. Generally, the portable subatmospheric pressure mechanism applies subatmospheric pressure to the wound to effectively remove wound fluids or exudates captured by the composite wound dressing, and to increase blood flow to the wound bed and enhance cellular stimulation of epithelial and subcutaneous tissue. The wound therapy system is entirely portable, i.e., it may be worn or carried by the subject such that the subject may be completely ambulatory during the therapy period. The wound therapy system including the subatmospheric pressure mechanism and components thereof may be entirely disposable after a predetermined period of use or may be individually disposable whereby some of the components are reused for a subsequent therapy application.
The wound therapy system of the present disclosure promotes healing of a wound in conjunction with subatmospheric negative pressure therapy. The system may incorporate a variety of wound dressings, subatmospheric pressure sources and pumps, and collection canisters. The attached figures illustrate exemplary embodiments of the present disclosure and are referenced to describe the embodiments depicted therein. Hereinafter, the disclosure will be described by explaining the figures wherein like reference numerals represent like parts throughout the several views.
Referring initially to
Wound dressing 102 may includes several components, namely, wound contact layer or member 108, a wound packing member or filler 110 supported by the contact member 108 and outer layer or cover member 112. Wound contact member 108 is adapted to substantially conform to the topography of a wound bed “W”. Wound contact member 108 is substantially porous or perforated to permit exudates to pass from the wound bed “W” through the wound contact member 108. The passage of wound exudates through the wound contact member 108 may be unidirectional such that wound exudates do not flow back to the wound bed “W”. Unidirectional flow may be encouraged by directional apertures formed in contact member 108 or a lamination of materials having absorption properties differing from those of contact member 108. A non-adherent material may be selected such that contact member 108 does not tend to cling to wound bed “W” or surrounding material when it is removed. One exemplary material that may be used as a contact member 108 is sold under the trademark XEROFLOW® by Tyco Healthcare Group LP (d/b/a Covidien).
Wound packing member 110 of wound dressing 102 is intended to absorb and transfer wound fluid and exudates. Wound packing member 110 is conformable to assume the shape of any wound bed “W”. Wound packing member 110 may be treated with agents such as polyhexamethylene biguanide (PHMB) to decrease the incidence of infection, or other medicants to promote healing of the wound. A suitable wound packing material 110 is the antimicrobial dressing sold under the trademark KERLEX® AMD by Tyco Healthcare Group LP (d/b/a Covidien).
Outer member or wound covering 112 encompasses the perimeter of the wound dressing 102 to surround wound bed “W” and to provide a liquid-tight seal around the perimeter “P” of the wound bed “W”. For instance, the sealing mechanism may be any biocompatible adhesive bonded to the perimeter of wound covering 112. Thus, wound covering 112 may act as both a microbial barrier and a fluid barrier to prevent contaminants from entering wound bed “W” and for maintaining the integrity thereof.
Wound covering 112 is typically a flexible material, e.g., resilient or elastomeric, that seals the top of wound dressing 102 to prevent passage of liquids or contamination to and from the wound dressing 102. Wound covering 112 may be formed from a moisture vapor permeable membrane to promote the exchange of oxygen moisture between the wound bed “W” and the atmosphere. A membrane that provides a sufficient moisture vapor transmission rate is a transparent membrane sold under the trade name POLYSKIN® II by Tyco Healthcare Group LP (d/b/a Covidien). A transparent membrane permits an assessment of wound conditions to be made without requiring removal of the wound covering 112. Alternatively, wound covering 112 may comprise an impermeable membrane or a substantially rigid membrane.
Wound covering 112 may include a port or connector 107 in fluid communication with the interior of wound dressing 102 to facilitate connection of wound dressing 102 to conduit or tubing 106. Conduit 106 defines a fluid flow path leading through wound therapy system 100. Connector 107 may be configured as a rigid or flexible, low-profile component, and may be adapted to receive conduit 106 in a releasable and fluid tight manner. A hollow interior of connector 107 provides fluid communication between conduit 106 and the interior of wound dressing 102. Connector 107 may have a valve 109 built therein, e.g., a one-way, valve to permit exudates to flow in one direction only, i.e., away from wound dressing 102 toward subatmospheric pressure mechanism 104. Connector 107 may be provided as a pre-affixed component of wound dressing 102, as a component of conduit 106, or entirely separate and connected thereto by conventional means. Alternatively, connector 107 may be eliminated if other provisions are made for providing fluid communication between wound dressing 102 and conduit 106.
Conduit 106 extends from subatmospheric pressure mechanism 104 to provide fluid communication between the interior of the wound dressing 102 and vacuum source 118. Any suitable conduit may be used including those fabricated from flexible elastomeric or polymeric materials. Conduit 106 may connect to vacuum source 118 or other system components by conventional air tight means such as friction fit, bayonet coupling, or barbed connectors. The conduit connections may be made permanent, or alternatively a quick-disconnect or other releasable means may be used to provide some adjustment flexibility to the apparatus.
Referring now to the schematic diagram of
Vacuum source or pump 118 may be a miniature pump or micropump that is biocompatible and adapted to maintain or draw adequate and therapeutic vacuum levels. The vacuum level of subatmospheric pressure achieved may be in the range of about 20 mmHg to about 500 mgHg. In some embodiments, about 75 mmHg and about 125 mmHg is desired or between about 35 mmHg and 75 mmHg may be desired. Vacuum source or pump 118 is actuated by actuator 120 which may be any means known by those skilled in the art, including, for example, AC motors. DC motors, voice coil actuators, solenoids, etc. Actuator 120 may be incorporated within pump 118.
On an exhaust side of vacuum source 118 fluid conduit 106 connects vacuum source 118 to collection canister 132. Conduit 106 may comprise the same material or construction along the entire length of the tubing or may assume an alternate form between vacuum source 118 and canister 132 than between wound dressing 102 and vacuum source 118. In the alternative, it may be separate tubing.
Power source 122 may be disposed within housing 117 or separately mountable to the housing 117. A suitable power source 122 includes alkaline batteries, wet cell batteries, dry cell batteries, nickel cadmium batteries, solar generated means, lithium batteries, NiMH batteries (nickel metal hydride) each of which may be of the disposable or rechargeable variety.
Referring again to
Turning now to
Collection bag 202 includes an expandable cavity 202a configured for receiving fluid “F”. Collection bag 202 is constructed with a hydrophobic membrane or other suitable material capable of permitting gases to escape cavity 202a. Alternatively, collection bag 202 may have a hydrophobic vent (not shown). Collection bag 202 is maintained in fluid communication with inlet port 206a. It is envisioned that collection bag 202 may be integrally formed with cover 206.
In operation, suction from pump 118 is provided to chamber 204a of container 204 through outlet port 206b. As a vacuum builds within chamber 204a suction is provided to wound dressing 102 to draw fluid “F” from wound “W”. As fluid “F” flows from wound “W” through inlet port 206a into cavity 202a of collection bag 202, any residual air or other gases in the system pass through collection bag 202. Cavity 202a expands to accommodate fluid “F” as the flow into collection bag 202 continues. Check valve 212 prevents fluid “F” from flowing from cavity 202a back towards wound dressing 102. Alternatively, check valve 212 may be formed on a distal end 106b of conduit 106. Collection bag 202 continues to expand as fluid “F” is drawn from wound “W”. Channel 207a formed in extension 207 of outlet port 206b is configured to permit the continued flow of suction into chamber 204a, thereby allowing collection bag 202 to expand to fill chamber 204a. Once collection bag 202 and/or chamber 204a is filled, cover 206 may be removed and collection bag 202 may be emptied and/or replaced.
With reference now to
Collection bag 202′ includes a bulb-shaped container constructed of rubber, polymer or other expandable material. As noted above, collection bag 202′ defines an expandable cavity 202a′. Collection bag 202′ further includes a hydrophobic plug 203′ for releasing gas from within cavity 202a′. As fluid “F” flows from conduit 106 through check valve 212′ and into cavity 202a′ of collection bag 202′, collection bag 202′ expands to accommodate the additional fluid. Any gas trapped within cavity 202a′ may be vented through hydrophobic plug 203′. Collection bag 202′ may be removed from conduit 106 and discarded as necessary. It is envisioned that collection bag 202′ may be reused. Collection bag 202′ may optionally include a tie, draw string or other suitable closure device for sealing cavity 202a′.
Turning to
With reference now to
Turning now to
Turning now to
A plunger 610 is retained within second chamber 608 of container 604. Plunger 610 is a substantially planar member including a hydrophobic membrane 612 and a seal 214a extending about a perimeter 214 of plunger 610. Plunger 610 is configured to be advanced in the direction of arrow A as suction is applied to outlet ports 604b and air is removed from within second chamber 608. Alternatively, it is envisioned that plunger 610 may be attached to an advancement mechanism, including hydraulic, pneumatic and motorized cylinder, for advancing plunger 610. Movement of plunger 610 towards outlets 604b (direction of arrow “A”) creates a vacuum in first chamber 606. The vacuum created in first chamber 606 provides suction to conduit 106′. As plunger 610 is drawn towards outlets 604b fluid “F” fills first and second chamber 606, 608. Residual air trapped within container 604 and/or conduit 106′ is exhausted though hydrophobic membrane 612. Once first and second chambers 606, 608 are filled, conduit 106′ is disconnected from container 604. Collection device 600 may include a valve or other mechanism (not shown) for draining container 604. Alternatively, collection device 600 may be discarded.
Turning now to
With reference now to
Intake mechanism 810 includes a bellows 812 and a float 814. Bellows 812 may be constructed of silicone or other suitable flexible material. Bellows 812 defines a passageway 812 therethrough in fluid communication with outlet port 806b. Bellows 812 includes openings 813 for receiving air from with chamber 804a. Float 814 may include an air bag, open cell material or other suitable material with a low mass. Float 814 may be affixed to an end of bellows 812. Alternatively, float 814 may be over-molded to bellows 812. Float 814 is configured to maintain at least one of openings 813 formed in bellows 812 above the level of fluid “F” as chamber 804a fills with fluid “F”. Bellows 812 and float 814 are configured such that as container 804 is transported, i.e. tilted or inverted, collection device 800 continues to collect fluid “F”.
Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, it is to be understood that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.
This application is a continuation application of U.S. application Ser. No. 15/192,605, filed on Jun. 24, 2016, which is a divisional application of U.S. application Ser. No. 14/486,338, filed on Sep. 15, 2014 and issued as U.S. Pat. No. 9,375,521, which is a continuation of U.S. application Ser. No. 13/777,171, filed on Feb. 26, 2013 and issued as U.S. Pat. No. 8,834,452, which is a continuation of and claims priority to U.S. application Ser. No. 12/124,707, filed May 21, 2008 and issued as U.S. Pat. No. 8,414,519.
Number | Name | Date | Kind |
---|---|---|---|
730062 | Widmer | Jun 1903 | A |
2468445 | Hurst | Apr 1949 | A |
3704709 | Sorenson et al. | Mar 1972 | A |
3866608 | Reynolds et al. | Feb 1975 | A |
3980166 | DeFeudis | Sep 1976 | A |
4063556 | Thomas et al. | Dec 1977 | A |
4112949 | Rosenthal et al. | Sep 1978 | A |
4136696 | Nehring | Jan 1979 | A |
4203445 | Jessup et al. | May 1980 | A |
4228798 | Deaton | Oct 1980 | A |
4266545 | Moss | May 1981 | A |
4293609 | Erickson | Oct 1981 | A |
4296748 | Kurtz et al. | Oct 1981 | A |
4321020 | Mital | Mar 1982 | A |
4331147 | Armstrong | May 1982 | A |
4373528 | Harle | Feb 1983 | A |
4376439 | Lauterjung | Mar 1983 | A |
4402687 | Denty et al. | Sep 1983 | A |
4429693 | Blake et al. | Feb 1984 | A |
4460642 | Errede et al. | Jul 1984 | A |
4551141 | McNeil | Nov 1985 | A |
4569674 | Phillips et al. | Feb 1986 | A |
4573992 | Marx | Mar 1986 | A |
4578060 | Huck et al. | Mar 1986 | A |
4585397 | Crawford et al. | Apr 1986 | A |
4604313 | McFarland et al. | Aug 1986 | A |
4642088 | Gunter | Feb 1987 | A |
4642093 | Harle | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4675010 | Siposs et al. | Jun 1987 | A |
4706830 | Wareing | Nov 1987 | A |
4738671 | Elliott et al. | Apr 1988 | A |
4747844 | Elliott | May 1988 | A |
4758238 | Sundblom et al. | Jul 1988 | A |
4767417 | Boehringer et al. | Aug 1988 | A |
4769019 | Kerwin | Sep 1988 | A |
4798578 | Ranford | Jan 1989 | A |
4822346 | Elliott | Apr 1989 | A |
4826494 | Richmond et al. | May 1989 | A |
4828546 | McNeil et al. | May 1989 | A |
4832299 | Gorton et al. | May 1989 | A |
4840770 | Walz et al. | Jun 1989 | A |
4850964 | Cotter | Jul 1989 | A |
4865816 | Walz et al. | Sep 1989 | A |
4870975 | Cronk et al. | Oct 1989 | A |
4889531 | D'Antonio et al. | Dec 1989 | A |
4925447 | Rosenblatt | May 1990 | A |
4950247 | Rosenblatt | Aug 1990 | A |
4955391 | Parker et al. | Sep 1990 | A |
4976694 | Schreibman | Dec 1990 | A |
4979944 | Luzsicza | Dec 1990 | A |
4981474 | Bopp et al. | Jan 1991 | A |
4988344 | Reising et al. | Jan 1991 | A |
4988345 | Reising | Jan 1991 | A |
4990137 | Graham | Feb 1991 | A |
5002529 | Cunningham | Mar 1991 | A |
5002534 | Rosenblatt | Mar 1991 | A |
5053026 | Andersen et al. | Oct 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5071104 | Witt et al. | Dec 1991 | A |
5073172 | Fell | Dec 1991 | A |
5112323 | Winkler et al. | May 1992 | A |
5135485 | Cohen et al. | Aug 1992 | A |
5141504 | Herweck et al. | Aug 1992 | A |
5149325 | Telang et al. | Sep 1992 | A |
5156602 | Steffler | Oct 1992 | A |
5158533 | Strauss et al. | Oct 1992 | A |
5188622 | Muller et al. | Feb 1993 | A |
5192439 | Roth et al. | Mar 1993 | A |
5219428 | Stern | Jun 1993 | A |
5246353 | Sohn | Sep 1993 | A |
5254080 | Lindsay | Oct 1993 | A |
5275585 | Olson | Jan 1994 | A |
5342329 | Croquevielle | Aug 1994 | A |
D352463 | Kubo | Nov 1994 | S |
5360445 | Goldowsky | Nov 1994 | A |
5374257 | Drainville et al. | Dec 1994 | A |
5382244 | Telang | Jan 1995 | A |
5386735 | Langdon | Feb 1995 | A |
5397299 | Karwoski et al. | Mar 1995 | A |
5399156 | Lindsay | Mar 1995 | A |
5411474 | Ott et al. | May 1995 | A |
5458586 | Adiletta | Oct 1995 | A |
5466229 | Elson | Nov 1995 | A |
5470585 | Gilchrist | Nov 1995 | A |
5484428 | Drainville et al. | Jan 1996 | A |
5496299 | Felix et al. | Mar 1996 | A |
5542939 | Onodera et al. | Aug 1996 | A |
5545151 | O'Connor et al. | Aug 1996 | A |
5549584 | Gross | Aug 1996 | A |
5582601 | Wortrich et al. | Dec 1996 | A |
5584824 | Gillette et al. | Dec 1996 | A |
5588958 | Cunningham et al. | Dec 1996 | A |
5591297 | Ahr | Jan 1997 | A |
5630855 | Lundbaeck | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
5656027 | Ellingboe | Aug 1997 | A |
5669892 | Keogh et al. | Sep 1997 | A |
5685214 | Neff et al. | Nov 1997 | A |
5688516 | Raad et al. | Nov 1997 | A |
5693013 | Geuder | Dec 1997 | A |
5707173 | Cottone et al. | Jan 1998 | A |
5762638 | Shikani et al. | Jun 1998 | A |
5776118 | Seifert et al. | Jul 1998 | A |
5785700 | Olson | Jul 1998 | A |
5787928 | Allen et al. | Aug 1998 | A |
5807359 | Bemis et al. | Sep 1998 | A |
D400249 | Holubar et al. | Oct 1998 | S |
5876387 | Killian et al. | Mar 1999 | A |
5882743 | McConnell | Mar 1999 | A |
D408625 | Barker | Apr 1999 | S |
5944703 | Dixon et al. | Aug 1999 | A |
5960837 | Cude | Oct 1999 | A |
5997733 | Wilbur et al. | Dec 1999 | A |
6010527 | Augustine et al. | Jan 2000 | A |
6071267 | Zamierowski | Jun 2000 | A |
6075177 | Bahia et al. | Jun 2000 | A |
6093230 | Johnson, III et al. | Jul 2000 | A |
6099493 | Swisher | Aug 2000 | A |
6102205 | Greff et al. | Aug 2000 | A |
6142982 | Hunt et al. | Nov 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6168758 | Forsberg et al. | Jan 2001 | B1 |
6180000 | Wilbur et al. | Jan 2001 | B1 |
6261276 | Reitsma | Jul 2001 | B1 |
D449891 | Moro | Oct 2001 | S |
6322546 | Steg | Nov 2001 | B1 |
6352233 | Barberich | Mar 2002 | B1 |
D456514 | Brown et al. | Apr 2002 | S |
6395955 | Roe et al. | May 2002 | B1 |
6458109 | Henley et al. | Oct 2002 | B1 |
6468199 | Satou et al. | Oct 2002 | B1 |
6478774 | Balugani et al. | Nov 2002 | B1 |
6501002 | Roe et al. | Dec 2002 | B1 |
D469175 | Hall et al. | Jan 2003 | S |
6547255 | Donaway et al. | Apr 2003 | B1 |
D475132 | Randolph | May 2003 | S |
6575333 | Raboin | Jun 2003 | B1 |
D477869 | Vijfvinkel | Jul 2003 | S |
D478659 | Hall et al. | Aug 2003 | S |
6620379 | Pluk et al. | Sep 2003 | B1 |
D481459 | Naham | Oct 2003 | S |
6635028 | Ielpo et al. | Oct 2003 | B1 |
6648862 | Watson | Nov 2003 | B2 |
6685681 | Lockwood et al. | Feb 2004 | B2 |
6723430 | Kurata et al. | Apr 2004 | B2 |
6752794 | Lockwood et al. | Jun 2004 | B2 |
6755807 | Risk, Jr. et al. | Jun 2004 | B2 |
6764462 | Risk, Jr. et al. | Jul 2004 | B2 |
6800074 | Henley | Oct 2004 | B2 |
6820483 | Beckerman | Nov 2004 | B1 |
6824533 | Risk, Jr. et al. | Nov 2004 | B2 |
6856821 | Johnson | Feb 2005 | B2 |
6868739 | Krivitski et al. | Mar 2005 | B1 |
6885116 | Knirck et al. | Apr 2005 | B2 |
D504953 | Ryan | May 2005 | S |
6936037 | Bubb et al. | Aug 2005 | B2 |
6951553 | Bubb et al. | Oct 2005 | B2 |
6955664 | D'Antonio | Oct 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
D516217 | Brown et al. | Feb 2006 | S |
7004915 | Boynton et al. | Feb 2006 | B2 |
D522657 | Murphy et al. | Jun 2006 | S |
7066949 | Gammons et al. | Jun 2006 | B2 |
7108683 | Zamierowski | Sep 2006 | B2 |
7128735 | Weston | Oct 2006 | B2 |
7153294 | Farrow | Dec 2006 | B1 |
D537944 | Eda et al. | Mar 2007 | S |
7198046 | Argenta et al. | Apr 2007 | B1 |
D544092 | Lewis | Jun 2007 | S |
7240676 | Rutter | Jul 2007 | B2 |
D548347 | Ichino et al. | Aug 2007 | S |
D551578 | Kuriger et al. | Sep 2007 | S |
D565177 | Locke et al. | Mar 2008 | S |
7381859 | Hunt et al. | Jun 2008 | B2 |
7438705 | Karpowicz et al. | Oct 2008 | B2 |
D580285 | Hendrickson et al. | Nov 2008 | S |
D581042 | Randolph et al. | Nov 2008 | S |
D581522 | Randolph et al. | Nov 2008 | S |
D585137 | Onoda et al. | Jan 2009 | S |
7503910 | Adahan | Mar 2009 | B2 |
D590934 | Randolph et al. | Apr 2009 | S |
7524315 | Blott et al. | Apr 2009 | B2 |
D593676 | Locke et al. | Jun 2009 | S |
D594114 | Locke et al. | Jun 2009 | S |
7553306 | Hunt et al. | Jun 2009 | B1 |
7569742 | Haggstrom et al. | Aug 2009 | B2 |
D602582 | Pidgeon et al. | Oct 2009 | S |
D602583 | Pidgeon et al. | Oct 2009 | S |
D602584 | Pidgeon et al. | Oct 2009 | S |
7604610 | Shener et al. | Oct 2009 | B2 |
7611500 | Lina et al. | Nov 2009 | B1 |
7615036 | Joshi et al. | Nov 2009 | B2 |
7625362 | Boehringer et al. | Dec 2009 | B2 |
7670323 | Hunt et al. | Mar 2010 | B2 |
7699823 | Haggstrom et al. | Apr 2010 | B2 |
7700819 | Ambrosio et al. | Apr 2010 | B2 |
7708724 | Weston | May 2010 | B2 |
7722582 | Lina et al. | May 2010 | B2 |
D617094 | Pidgeon et al. | Jun 2010 | S |
D617461 | Kaushal et al. | Jun 2010 | S |
7731702 | Bybordi et al. | Jun 2010 | B2 |
7758554 | Lina et al. | Jul 2010 | B2 |
7759537 | Bishop et al. | Jul 2010 | B2 |
7759539 | Shaw et al. | Jul 2010 | B2 |
7775998 | Riesinger | Aug 2010 | B2 |
7779625 | Joshi et al. | Aug 2010 | B2 |
7794450 | Blott et al. | Sep 2010 | B2 |
D625801 | Pidgeon et al. | Oct 2010 | S |
7837673 | Vogel | Nov 2010 | B2 |
7846141 | Weston | Dec 2010 | B2 |
D630313 | Pidgeon et al. | Jan 2011 | S |
D630725 | Pidgeon et al. | Jan 2011 | S |
7862339 | Mulligan | Jan 2011 | B2 |
7927318 | Risk, Jr. et al. | Apr 2011 | B2 |
7964766 | Blott et al. | Jun 2011 | B2 |
7998125 | Weston | Aug 2011 | B2 |
8021348 | Risk, Jr. et al. | Sep 2011 | B2 |
8048046 | Hudspeth et al. | Nov 2011 | B2 |
8061360 | Locke et al. | Nov 2011 | B2 |
8062272 | Weston | Nov 2011 | B2 |
8080702 | Blott et al. | Dec 2011 | B2 |
8100873 | Jaeb et al. | Jan 2012 | B2 |
8162909 | Blott et al. | Apr 2012 | B2 |
8172817 | Michaels et al. | May 2012 | B2 |
8235972 | Adahan | Aug 2012 | B2 |
8240470 | Pidgeon et al. | Aug 2012 | B2 |
8246607 | Karpowicz et al. | Aug 2012 | B2 |
8257327 | Blott et al. | Sep 2012 | B2 |
8267909 | Clementi et al. | Sep 2012 | B2 |
8267918 | Johnson et al. | Sep 2012 | B2 |
8294586 | Pidgeon et al. | Oct 2012 | B2 |
8308714 | Weston et al. | Nov 2012 | B2 |
8323264 | Weston et al. | Dec 2012 | B2 |
8333744 | Hartwell et al. | Dec 2012 | B2 |
8348910 | Blott et al. | Jan 2013 | B2 |
8372049 | Jaeb et al. | Feb 2013 | B2 |
8372050 | Jaeb et al. | Feb 2013 | B2 |
8414519 | Hudspeth | Apr 2013 | B2 |
8444392 | Turner et al. | May 2013 | B2 |
8460255 | Joshi et al. | Jun 2013 | B2 |
8494349 | Gordon | Jul 2013 | B2 |
8535283 | Heaton et al. | Sep 2013 | B2 |
8551061 | Hartwell et al. | Oct 2013 | B2 |
8556871 | Mormino et al. | Oct 2013 | B2 |
8569566 | Blott et al. | Oct 2013 | B2 |
8617129 | Hartwell | Dec 2013 | B2 |
8622981 | Hartwell et al. | Jan 2014 | B2 |
8641691 | Fink et al. | Feb 2014 | B2 |
8679079 | Heaton et al. | Mar 2014 | B2 |
8747376 | Locke et al. | Jun 2014 | B2 |
8771259 | Karpowicz et al. | Jul 2014 | B2 |
8814840 | Evans et al. | Aug 2014 | B2 |
8814841 | Hartwell | Aug 2014 | B2 |
8821458 | Locke et al. | Sep 2014 | B2 |
8834452 | Hudspeth | Sep 2014 | B2 |
8843327 | Vernon-Harcourt et al. | Sep 2014 | B2 |
8845603 | Middleton et al. | Sep 2014 | B2 |
8864748 | Coulthard et al. | Oct 2014 | B2 |
8974429 | Gordon et al. | Mar 2015 | B2 |
9019681 | Locke et al. | Apr 2015 | B2 |
9050399 | Hartwell | Jun 2015 | B2 |
9205183 | Hartwell et al. | Dec 2015 | B2 |
9227000 | Fink et al. | Jan 2016 | B2 |
9320838 | Hartwell et al. | Apr 2016 | B2 |
9375521 | Hudspeth | Jun 2016 | B2 |
9408954 | Gordon et al. | Aug 2016 | B2 |
9561312 | Heaton et al. | Feb 2017 | B2 |
9636440 | Weston et al. | May 2017 | B2 |
9642955 | Fink et al. | May 2017 | B2 |
9974890 | Hudspeth | May 2018 | B2 |
20020026160 | Takahashi et al. | Feb 2002 | A1 |
20020145012 | Ho | Oct 2002 | A1 |
20020156464 | Blischak et al. | Oct 2002 | A1 |
20030065292 | Darouiche | Apr 2003 | A1 |
20030093041 | Risk, Jr. et al. | May 2003 | A1 |
20030097100 | Watson | May 2003 | A1 |
20030101826 | Neubert | Jun 2003 | A1 |
20030163101 | Say | Aug 2003 | A1 |
20030164600 | Dunn et al. | Sep 2003 | A1 |
20030181850 | Diamond et al. | Sep 2003 | A1 |
20030212357 | Pace | Nov 2003 | A1 |
20030235635 | Fong et al. | Dec 2003 | A1 |
20040006321 | Cheng et al. | Jan 2004 | A1 |
20040054338 | Bybordi | Mar 2004 | A1 |
20040064132 | Boehringer et al. | Apr 2004 | A1 |
20040087918 | Johnson, III et al. | May 2004 | A1 |
20040102743 | Walker | May 2004 | A1 |
20040116551 | Terry | Jun 2004 | A1 |
20040122383 | Romano et al. | Jun 2004 | A1 |
20040153029 | Blischak et al. | Aug 2004 | A1 |
20040167482 | Watson | Aug 2004 | A1 |
20040180093 | Burton et al. | Sep 2004 | A1 |
20040193218 | Butler | Sep 2004 | A1 |
20040233631 | Lord | Nov 2004 | A1 |
20040260230 | Randolph | Dec 2004 | A1 |
20050070858 | Lockwood et al. | Mar 2005 | A1 |
20050124966 | Karpowicz et al. | Jun 2005 | A1 |
20050144711 | Valadez et al. | Jul 2005 | A1 |
20050166683 | Krivitski et al. | Aug 2005 | A1 |
20050187528 | Berg | Aug 2005 | A1 |
20050209560 | Boukhny et al. | Sep 2005 | A1 |
20050248045 | Anthony | Nov 2005 | A1 |
20060009744 | Erdman et al. | Jan 2006 | A1 |
20060029675 | Ginther | Feb 2006 | A1 |
20060059980 | Matsubara et al. | Mar 2006 | A1 |
20060129137 | Lockwood et al. | Jun 2006 | A1 |
20060144440 | Merkle | Jul 2006 | A1 |
20060149171 | Vogel et al. | Jul 2006 | A1 |
20060280650 | Wong et al. | Dec 2006 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070021697 | Ginther et al. | Jan 2007 | A1 |
20070027433 | Garcia et al. | Feb 2007 | A1 |
20070032741 | Hibner et al. | Feb 2007 | A1 |
20070032763 | Vogel | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070078444 | Larsson | Apr 2007 | A1 |
20070118096 | Smith et al. | May 2007 | A1 |
20070135779 | Lalomia et al. | Jun 2007 | A1 |
20070141128 | Blott et al. | Jun 2007 | A1 |
20070179460 | Adahan | Aug 2007 | A1 |
20070180904 | Gao | Aug 2007 | A1 |
20070219513 | Lina et al. | Sep 2007 | A1 |
20070219532 | Karpowicz et al. | Sep 2007 | A1 |
20070219535 | Phung et al. | Sep 2007 | A1 |
20070233022 | Henley et al. | Oct 2007 | A1 |
20070244451 | Romano et al. | Oct 2007 | A1 |
20070260226 | Jaeb et al. | Nov 2007 | A1 |
20080011667 | Ruschke | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080033400 | Holper et al. | Feb 2008 | A1 |
20080051708 | Kumar et al. | Feb 2008 | A1 |
20080071234 | Kelch et al. | Mar 2008 | A1 |
20080071235 | Locke et al. | Mar 2008 | A1 |
20080082040 | Kubler et al. | Apr 2008 | A1 |
20080082077 | Williams | Apr 2008 | A1 |
20080108977 | Heaton et al. | May 2008 | A1 |
20080125697 | Gao | May 2008 | A1 |
20080125698 | Gerg et al. | May 2008 | A1 |
20080132855 | Romano et al. | Jun 2008 | A1 |
20080183233 | Koch et al. | Jul 2008 | A1 |
20080200905 | Heaton et al. | Aug 2008 | A1 |
20080234641 | Locke et al. | Sep 2008 | A1 |
20080243096 | Svedman | Oct 2008 | A1 |
20080281281 | Meyer et al. | Nov 2008 | A1 |
20090005746 | Nielsen et al. | Jan 2009 | A1 |
20090043268 | Eddy et al. | Feb 2009 | A1 |
20090101219 | Martini et al. | Apr 2009 | A1 |
20090157016 | Adahan | Jun 2009 | A1 |
20090204049 | Lee | Aug 2009 | A1 |
20090227969 | Jaeb et al. | Sep 2009 | A1 |
20090234306 | Vitaris | Sep 2009 | A1 |
20090234309 | Vitaris et al. | Sep 2009 | A1 |
20090240185 | Jaeb et al. | Sep 2009 | A1 |
20090240218 | Braga et al. | Sep 2009 | A1 |
20090254066 | Heaton | Oct 2009 | A1 |
20090275922 | Coulthard et al. | Nov 2009 | A1 |
20090312725 | Braga | Dec 2009 | A1 |
20100022990 | Karpowicz et al. | Jan 2010 | A1 |
20100030132 | Niezgoda et al. | Feb 2010 | A1 |
20100036333 | Schenk, III et al. | Feb 2010 | A1 |
20100042059 | Pratt et al. | Feb 2010 | A1 |
20100121257 | King | May 2010 | A1 |
20100126268 | Baily et al. | May 2010 | A1 |
20100145289 | Line et al. | Jun 2010 | A1 |
20100211030 | Turner et al. | Aug 2010 | A1 |
20100268179 | Kelch et al. | Oct 2010 | A1 |
20100280435 | Raney et al. | Nov 2010 | A1 |
20100280536 | Hartwell | Nov 2010 | A1 |
20100305490 | Coulthard et al. | Dec 2010 | A1 |
20100324510 | Andresen et al. | Dec 2010 | A1 |
20110028918 | Hartwell | Feb 2011 | A1 |
20110054421 | Hartwell | Mar 2011 | A1 |
20110054810 | Turner | Mar 2011 | A1 |
20110063117 | Turner | Mar 2011 | A1 |
20110066110 | Fathallah et al. | Mar 2011 | A1 |
20110077605 | Karpowicz et al. | Mar 2011 | A1 |
20110092958 | Jacobs | Apr 2011 | A1 |
20110112493 | Koch et al. | May 2011 | A1 |
20110130712 | Topaz | Jun 2011 | A1 |
20110172615 | Greener | Jul 2011 | A2 |
20110172616 | Hartwell et al. | Jul 2011 | A1 |
20110251569 | Turner et al. | Oct 2011 | A1 |
20110295220 | Heaton et al. | Dec 2011 | A1 |
20110313375 | Michaels | Dec 2011 | A1 |
20120001762 | Turner et al. | Jan 2012 | A1 |
20120035560 | Eddy et al. | Feb 2012 | A1 |
20120041399 | Blott et al. | Feb 2012 | A1 |
20130090613 | Kelch et al. | Apr 2013 | A1 |
20130090615 | Jaeb et al. | Apr 2013 | A1 |
20130102979 | Coulthard et al. | Apr 2013 | A1 |
20130116635 | Fleischmann | May 2013 | A1 |
20130138054 | Fleischmann | May 2013 | A1 |
20130144235 | Augustine et al. | Jun 2013 | A1 |
20130338614 | Heaton et al. | Dec 2013 | A1 |
20140100538 | Hartwell | Apr 2014 | A1 |
20140100539 | Coulthard et al. | Apr 2014 | A1 |
20140155849 | Heaton et al. | Jun 2014 | A1 |
20140163491 | Schuessler | Jun 2014 | A1 |
20140188061 | Locke et al. | Jul 2014 | A1 |
20140200535 | Locke et al. | Jul 2014 | A1 |
20140236106 | Locke et al. | Aug 2014 | A1 |
20140276490 | Locke et al. | Sep 2014 | A1 |
20140276491 | Luckemeyer et al. | Sep 2014 | A1 |
20140276497 | Robinson | Sep 2014 | A1 |
20140309601 | Hall et al. | Oct 2014 | A1 |
20140320283 | Lawhorn | Oct 2014 | A1 |
20150073363 | Kelch et al. | Mar 2015 | A1 |
20150343122 | Hartwell | Dec 2015 | A1 |
20160144081 | Wiesner | May 2016 | A1 |
20160151547 | Hartwell et al. | Jun 2016 | A1 |
20160184498 | Jaeb et al. | Jun 2016 | A1 |
20160331877 | Braga et al. | Nov 2016 | A1 |
20180318474 | Breitweiser et al. | Nov 2018 | A1 |
20180353352 | Fink et al. | Dec 2018 | A1 |
20190009008 | Hartwell | Jan 2019 | A1 |
20190060532 | Hartwell et al. | Feb 2019 | A1 |
Number | Date | Country |
---|---|---|
2623320 | Jul 2004 | CN |
39 16 648 | Sep 1990 | DE |
43 12 852 | Oct 1993 | DE |
0 358 302 | Mar 1990 | EP |
1 476 217 | Mar 2008 | EP |
2 079 507 | Jul 2009 | EP |
2 248 546 | Nov 2010 | EP |
2 687 245 | Jan 2014 | EP |
2 711 034 | Mar 2014 | EP |
2 305 325 | Apr 2014 | EP |
2 345 437 | Apr 2014 | EP |
1415096 | Nov 1975 | GB |
2235877 | Mar 1991 | GB |
2418738 | Apr 2006 | GB |
2000-202022 | Jul 2000 | JP |
WO 198700439 | Jan 1987 | WO |
WO 199605873 | Feb 1996 | WO |
WO 199619335 | Jun 1996 | WO |
WO 2003022333 | Mar 2003 | WO |
WO 2003053346 | Jul 2003 | WO |
WO 2003074106 | Sep 2003 | WO |
WO 2003101508 | Dec 2003 | WO |
WO 2004060225 | Jul 2004 | WO |
WO 2005105179 | Nov 2005 | WO |
WO 2005123170 | Dec 2005 | WO |
WO 2006052745 | May 2006 | WO |
WO 2006052839 | May 2006 | WO |
WO-2007087808 | Aug 2007 | WO |
WO-2007087809 | Aug 2007 | WO |
WO 2008036344 | Mar 2008 | WO |
WO 2008036360 | Mar 2008 | WO |
WO 2008039223 | Apr 2008 | WO |
WO 2008039314 | Apr 2008 | WO |
WO 2008048481 | Apr 2008 | WO |
WO 2008049029 | Apr 2008 | WO |
WO 2009004289 | Jan 2009 | WO |
WO 2009077722 | Jun 2009 | WO |
WO 2009086580 | Jul 2009 | WO |
WO 2009124100 | Oct 2009 | WO |
WO 2009151645 | Dec 2009 | WO |
WO 2010017484 | Feb 2010 | WO |
WO 2010039481 | Apr 2010 | WO |
WO 2014113504 | Jul 2014 | WO |
WO 2014107285 | Sep 2014 | WO |
WO 2014143488 | Sep 2014 | WO |
Entry |
---|
U.S. Appl. No. 14/019,932, filed Sep. 6, 2013, Hartwell. |
U.S. Appl. No. 14/486,338, filed Sep. 15, 2014, Hudspeth et al. |
U.S. Appl. No. 14/878,975, filed Oct. 8, 2015, Wudyka. |
U.S. Appl. No. 15/493,058, filed Apr. 20, 2017, Fink et al. |
U.S. Appl. No. 29/574,909, filed Aug. 19, 2016, Bjelovuk et al. |
U.S. Appl. No. 29/574,925, filed Aug. 19, 2016, Bjelovuk et al. |
The American Heritage® Science Dictionary, definition of “Evaporation”, Copyright © 2005, in 3 pages. |
Huntleigh Healthcare, “Negative Pressure Positive Outcomes” WoundASSIST TNP Console and Canister Brochure, 2007, in 6 pages. |
“Vivano—Product application description,” Hartmann Vivano, accessed Feb. 28, 2013. URL: http://www.vivanosystem.info/20809.php. |
KCI, “V.A.C. Freedom User's Guide”, May 2002, in 16 pages. |
Number | Date | Country | |
---|---|---|---|
20180333521 A1 | Nov 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14486338 | Sep 2014 | US |
Child | 15192605 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15192605 | Jun 2016 | US |
Child | 15984077 | US | |
Parent | 13777171 | Feb 2013 | US |
Child | 14486338 | US | |
Parent | 12124707 | May 2008 | US |
Child | 13777171 | US |